Latest filing published 11 Jun 2021 for Panbela Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Suzanne Gagnon: trading record in brief
All filings by Suzanne Gagnon on record concern Panbela Therapeutics, Inc., in the capacity of board member. In total, 5 filings cover trades dated from 24 June 2016 to 29 April 2021.
Purchases make up the whole of the open-market record (2 purchases). The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 11 June 2021 came the latest disclosure, a transaction in Panbela Therapeutics, Inc. The clock since the last published purchase (24 September 2019) now reads 2,602 days. Filings reach the SEC (Form 4) feed a median of 43 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Suzanne Gagnon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,142 shares0Common StockSEC:0001437749-21-014548:0
1 of 1 declaration